|
Name |
9-Octadecenoic acid, ethyl ester
|
Molecular Formula | C20H38O2 | |
IUPAC Name* |
ethyl (E)-octadec-9-enoate
|
|
SMILES |
CCCCCCCC/C=C/CCCCCCCC(=O)OCC
|
|
InChI |
InChI=1S/C20H38O2/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22-4-2/h11-12H,3-10,13-19H2,1-2H3/b12-11+
|
|
InChIKey |
LVGKNOAMLMIIKO-VAWYXSNFSA-N
|
|
Synonyms |
6114-18-7; 9-Octadecenoic acid, ethyl ester; Ethyl elaidate; Elaidic acid ethyl ester; ethyl (E)-octadec-9-enoate; ethyl (9E)-octadec-9-enoate; ethyl octadec-9-enoate; (E)-ethyl octadec-9-enoate; Oleic acid ethyl ester; (E)-9-Octadecenoic acid ethyl ester; Ethyl 9-octadecenoate; delta 9 trans-Octadecenoic acid ethyl ester; ELAIDICACIDETHYLESTER; Ethyl Z-9-octadecenoate; EINECS 228-082-5; 9-Octadecenoic acid, ethyl ester, (E)-; starbld0002556; SCHEMBL2798; Ethyl (9E)-9-octadecenoate; Ethyl (9Z)-9-octadecenoate; SCHEMBL874561; QSPL 075; 9-Octadecenoic acid ethyl ester; Elaidic acid ethyl ester, liquid; FEMA 2450; DTXSID00110052; CHEBI:180949; 6512-99-8; LMFA07010880; ZINC59868199; (E)-9-Octadeccenoic acid ethy ester; trans-9-Octadecenoic acid ethyl ester; AKOS015901517; (9E)-9-Octadecenoic Acid Ethyl Ester; LS-14830; D91817; EN300-21687478; J-002605; Q63409543
|
|
CAS | 6114-18-7 | |
PubChem CID | 5364430 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 310.5 | ALogp: | 8.0 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 17 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 26.3 | Aromatic Rings: | 0 |
Heavy Atoms: | 22 | QED Weighted: | 0.184 |
Caco-2 Permeability: | -4.784 | MDCK Permeability: | 0.00002460 |
Pgp-inhibitor: | 0.01 | Pgp-substrate: | 0.002 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.662 |
30% Bioavailability (F30%): | 0.996 |
Blood-Brain-Barrier Penetration (BBB): | 0.097 | Plasma Protein Binding (PPB): | 99.41% |
Volume Distribution (VD): | 3.673 | Fu: | 0.97% |
CYP1A2-inhibitor: | 0.534 | CYP1A2-substrate: | 0.187 |
CYP2C19-inhibitor: | 0.47 | CYP2C19-substrate: | 0.059 |
CYP2C9-inhibitor: | 0.297 | CYP2C9-substrate: | 0.958 |
CYP2D6-inhibitor: | 0.532 | CYP2D6-substrate: | 0.082 |
CYP3A4-inhibitor: | 0.47 | CYP3A4-substrate: | 0.063 |
Clearance (CL): | 3.231 | Half-life (T1/2): | 0.41 |
hERG Blockers: | 0.22 | Human Hepatotoxicity (H-HT): | 0.019 |
Drug-inuced Liver Injury (DILI): | 0.066 | AMES Toxicity: | 0.002 |
Rat Oral Acute Toxicity: | 0.016 | Maximum Recommended Daily Dose: | 0.021 |
Skin Sensitization: | 0.962 | Carcinogencity: | 0.046 |
Eye Corrosion: | 0.941 | Eye Irritation: | 0.947 |
Respiratory Toxicity: | 0.824 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001670 | 1.000 | D0O1PH | 0.697 | ||||
ENC001688 | 0.836 | D0O1TC | 0.500 | ||||
ENC001627 | 0.792 | D07ILQ | 0.500 | ||||
ENC001643 | 0.784 | D0OR6A | 0.455 | ||||
ENC001648 | 0.784 | D0Z5SM | 0.444 | ||||
ENC001687 | 0.783 | D05ATI | 0.429 | ||||
ENC001583 | 0.775 | D0UE9X | 0.429 | ||||
ENC001699 | 0.765 | D00MLW | 0.427 | ||||
ENC001602 | 0.765 | D00FGR | 0.394 | ||||
ENC001555 | 0.765 | D0G2KD | 0.389 |